glp-1 blood brain barrier uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics A schematic representation of the
Description
What is compounded semaglutide

Frontiers in Immunology, 6, 120

A separate nationwide cohort of older Danish patients found an 11% reduced dementia risk on GLP-1s

But most people who have heard the name have no idea what it actually is, how it differs from older oral options, or whether it's the right fit for their metabolic goals

Lynn AM, Harmsen WS, Aniwan S, Tremaine WJ, Loftus EV
